Reporting obligations for prime brokers - AIFMD Provision

From The Jolly Contrarian

Revision as of 12:14, 30 January 2015 by Amwelladmin (talk | contribs) (Created page with "{{aifmdsnap|91(3)}} {{aifmdanatomy}}")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Paragraph 91(3), AIFMD

AIFMD, 91(3)
Template:AIFMD 91(3)
(view template)

AIFMD

This is an article about Alternative Investment Funds Management Directive (2011/61/EU (EUR Lex)) and the AIFMD Implementing Regulation 231/2013 (EUR Lex).

Navigation - directive 2011/61/EU (EUR Lex): 21 | 21(8) | 21(11) | 21(14) | 36 (depo-lite) | 36(1)
Navigation - implementing regulation 231/2013 (EUR Lex): DR76 (objective reason) | DR91 (reporting obligations for prime brokers)
AIFMD Anatomy
Anatomy™: AIFMD | CASS | COBS | Conference calls | Confis | CRR | CSA | EMIR | Equity Derivatives | FOA PCA | FUND | GMRA | GMSLA | ISDA | OSLA | PB | Swapclear | UCITS

Retrieved from "https://jollycontrarian.com/index.php?title=Reporting_obligations_for_prime_brokers_-_AIFMD_Provision&oldid=8802"